Skip to main content
Log in

Intérêts potentiels de la citrulline en réanimation

Potential interests of citrulline in critically ill patients

  • Mise au Point / Update
  • Published:
Réanimation

Résumé

De par son métabolisme très particulier, la citrulline (CIT) est un biomarqueur reconnu de la masse intestinale fonctionnelle. Chez le malade agressé et infecté en réanimation, la CIT plasmatique est souvent effondrée, de l’ordre de 10 μmol/L (valeurs normales: 38±8 μmol/L). Cette perturbation est multifactorielle car, chez ces patients, il peut exister une augmentation du recyclage de la CIT en arginine et/ou une déplétion en ce second acide aminé. Enfin, l’existence d’une défaillance multi-organique complique encore les choses. Des études expérimentales, réalisées dans des modèles murins de sepsis, fournissent des résultats prometteurs, en particulier sur la microcirculation intestinale. Il reste à confirmer ces résultats en clinique.

Abstract

Due to its highly specific metabolism, citrulline (CIT) is now recognized as a biomarker of functional intestinal mass. In the stressed and septic critically ill patient, plasma CIT is often very low at ∼10 μmol/L (normal range: 38±8 μmol/L). These abnormal values are difficult to interpret as patients may present increased CIT recycling into arginine and/or arginine depletion. Additionally, multiple organ failure may further make this issue complex. Experimental studies in rodent models of sepsis have raised promising results, particularly regarding gut microcirculation, which now need to be confirmed by ongoing randomized clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Références

  1. Luiking YC, Engelen MP, Deutz NE (2010) Regulation of nitric oxide production in health and disease. Curr Opin Clin Nutr Metab Care 13:97–104

    Article  PubMed  CAS  Google Scholar 

  2. Wu G, Morris SM Jr (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336:1–17

    PubMed  CAS  Google Scholar 

  3. Cynober L, Moinard C, De Bandt JP (2010) The 2009 ESPEN Sir David Cuthbertson. Citrulline: A new major signaling molecule or just another player in the pharmaconutrition game? Clin Nutr 29:545–551

    Article  PubMed  CAS  Google Scholar 

  4. Curis E, Crenn P, Cynober L (2007) Citrulline and the gut. Curr Opin Clin Nutr Metab Care 10:620–626

    Article  PubMed  CAS  Google Scholar 

  5. Cynober L (2013) Amino acid metabolism. In: Lennarz WJ and Lane, MD (eds.) The Encyclopedia of Biological Chemistry, Waltham MA. Academic Press 1:91–96

    Article  Google Scholar 

  6. Crenn P, Coudray-Lucas C, Thuillier F, et al (2000) Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 119:1496–1505

    Article  PubMed  CAS  Google Scholar 

  7. Osowska S, Moinard C, Neveux N, et al (2004) Citrulline increases arginine pools and restores nitrogen balance after massive intestinal resection. Gut 53:1781–1786

    Article  PubMed  CAS  Google Scholar 

  8. Wakabayashi Y (2004) The glutamate crossway. In: Cynober L. Metabolic and therapeutic aspects of amino-acids in clinical nutrition. Boca Raton: CRC Press 135–152

    Google Scholar 

  9. Meijer AJ (2004) Ureagenesis and ammoniagenesis: an update. In: Cynober L. Metabolic and therapeutic aspects of amino acids in clinical nutrition. Boca Raton: CRC Press 111–122

    Google Scholar 

  10. Curis E, Nicolis I, Moinard C, et al (2005) Almost all about citrulline in mammals. Amino Acids 29:177–205

    Article  PubMed  CAS  Google Scholar 

  11. Ligthart-Melis GC, Deutz NE (2011) Is glutamine still an important precursor of citrulline? Am J Physiol Endocrinol Metab 301: E264–E266

    Article  PubMed  CAS  Google Scholar 

  12. Marini JC (2012) Arginine and ornithine are the main precursors for citrulline synthesis in mice. J Nutr 142:572–580

    Article  PubMed  CAS  Google Scholar 

  13. Marini JC, Didelija IC, Castillo L, Lee B (2010) Plasma arginine and ornithine are the main citrulline precursors in mice infused with arginne-free diets. J Nutr 140:1432–1437

    Article  PubMed  CAS  Google Scholar 

  14. Piton G, Manzon C, Cypriani B, et al (2011) Acute intestinal failure in critically ill patients: is plasma citrulline the right marker? Intensive Care Med 37:911–917

    Article  PubMed  Google Scholar 

  15. Luiking YC, Poeze M, Ramsay G, Deutz NE (2009) Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production. Am J Clin Nutr 89:142–152

    Article  PubMed  CAS  Google Scholar 

  16. Manzanares W, Heyland DK (2012) Pharmaconutrition with arginine decreases bacterial translocation in an animal model of severe trauma. Is a clinical study justified? Time is now! Crit Care Med 40:350–352

    Article  PubMed  Google Scholar 

  17. Neveux N, David P, Cynober L (2004) Measurement of amino acid concentrations in biological fluid and tissues using ion exchange chromatography. In: Cynober L. Metabolic and therapeutic aspects of amino acids in clinical nutrition. Boca Raton: CRC Press 17–28

    Google Scholar 

  18. Brasse-Lagnel C, Lavoinne A, Fairand A, et al (2005) IL-1β stimulates argininosuccinate synthetase gene expression through NF-κB in Caco-2 cells. Biochimie 87:403–409

    Article  PubMed  CAS  Google Scholar 

  19. Popovic PJ, Zeh HJ, Ochoa JB (2007) Arginine and immunity. J Nutr 137:1681S–1686S

    PubMed  CAS  Google Scholar 

  20. Oudemans-van Straaten HM, Bosman RJ, Treskes M, et al (2001) Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 27:84–90

    Article  PubMed  CAS  Google Scholar 

  21. Kao CC, Bandi V, Guntupalli KK, et al (2009) Arginine, citrulline and nitric oxide metabolism in sepsis. Clin Sci 117:23–30

    Article  PubMed  CAS  Google Scholar 

  22. Cynober L (2013) Citrulline: Just a biomarker or a conditionally essential amino acid and a pharmaconutrient in critically ill patients? Crit Care 17:122

    Article  PubMed  Google Scholar 

  23. Cynober L (2002) Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition 18:761–766

    Article  PubMed  CAS  Google Scholar 

  24. Bryk J, Ochoa JB, Correia MI, et al (2008) Effect of citrulline and glutamine on nitric oxide production in RAW 264.7 cells in an arginine-depleted environment. JPEN J Parenter Enteral Nutr 32:377–383

    Article  PubMed  CAS  Google Scholar 

  25. Erez A, Nagamani SCS, Shchelochkov OA, et al (2011) Requirement of argininosuccinate lyase for systemic nitric oxide production. Nature Med 17:1619–1626

    Article  PubMed  CAS  Google Scholar 

  26. Van Waardenburg DA, de Betue CT, Luiking YC, et al (2007) Plasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation. Am J Clin Nutr 86:1438–1444

    PubMed  Google Scholar 

  27. Crenn P, Neveux N, Chevret S, et al (2010) Plasma citrulline kinetic and its relation with glutamine, arginine, TNFα and IL10 in ICU septic shock patients with multiple organ failure. Clin Nutr 5(suppl 2):S214–S215 (résumé)

    Google Scholar 

  28. Mills CD (2001) Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue. Crit Rev Immunol 21:399–426

    Article  PubMed  CAS  Google Scholar 

  29. Crenn P, Hanachi M, Neveux N, Cynober L (2011) La citrullinémie: un biomarqueur de la fonctionnalité intestinale. Ann Biol Clin 69:513–521

    CAS  Google Scholar 

  30. Grimaldi D, Guivarch E, Neveux N, et al (2013) Markers of intestinal injury are associated with endotoxemia in successfully resuscitated patients. Resuscitation 84:60–65

    Article  PubMed  CAS  Google Scholar 

  31. Crenn P, Annane D (2010) Mesure de la fonctionnalité intestinale en réanimation par la détermination de la citrullinémie. Réanimation 19:393–398

    Article  Google Scholar 

  32. Peters JH, Beishuizen A, Keur MB, et al (2011) Assessment of small bowel function in critical illness: potential role of citrulline metabolism. J Intensive Care Med 26:105–110

    Article  PubMed  CAS  Google Scholar 

  33. Piton G, Manzon C, Monnet E, et al (2010) Plasma citrulline kinetics and prognostic value in critically ill patients. Intensive Care Med 36:702–706

    Article  PubMed  CAS  Google Scholar 

  34. Noordally SO, Sohawon S, Semlali H, et al (2012) Is there a correlation between circulating levels of citrulline and intestinal dysfunction in the critically ill? Nutr Clin Pract 27:527–532

    Article  PubMed  Google Scholar 

  35. Ware LB, Magarik JA, Wickersham N, et al (2013) Low plasma citrulline levels are associated with acute respiratory distress syndrome in patients with severe sepsis. Crit Care 2013;17:R10

    Article  PubMed  Google Scholar 

  36. Moinard C, Nicolis I, Neveux N, et al (2008) Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the citrudose pharmacokinetic study. Brit J Nutr 99:855–862

    Article  PubMed  CAS  Google Scholar 

  37. Schwedhelm E, Maas M, Freese R, et al (2008) Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and Larginine: impact on nitric oxide metabolism. Br J Clin Pharmacol 65:51–59

    Article  PubMed  CAS  Google Scholar 

  38. Wijnands KA, Vink H, Briedé JJ, et al (2012) Citrulline a more suitable substrate than arginine to restore NO production and the microcirculation during endotoxemia. PLoS One 7:e37439

    Article  PubMed  CAS  Google Scholar 

  39. Elwafi F, Curis E, Zerrouk N, et al (2012) Endotoxemia affects citrulline, arginine and glutamine bioavailability. Eur J Clin Invest 42:282–289

    Article  PubMed  CAS  Google Scholar 

  40. Osowska S, Neveux N, Nakib S, et al (2008) Impairment of arginine metabolism in rats after massive intestinal resection: effect of parenteral nutrition supplemented with citrulline compared with arginine. Clin Sci 115:159–166

    Article  PubMed  CAS  Google Scholar 

  41. Batista MA, Nicoli JR, dos Santos Martins F, et al (2012) Pretreatment with citrulline improves but barrier after intestinal obstruction in mice. JPEN J Parenter Enteral Nutr 36:69–76

    Article  PubMed  CAS  Google Scholar 

  42. Asgeirsson T, Zhang S, Nunoo R, et al (2011) Citrulline: A potential immunomodulator in septis. Surgery 150:744–751

    Article  PubMed  Google Scholar 

  43. Cynober L, De Bandt JP, Moinard C (2013) Leucine and citrulline: two major regulators of protein turnover. In: Singer P (ed): Nutrition in intensive Care Medicine: Beyond Physiology. World Rev Nutr Diet. Basel: Karger 105:97–105

    Article  Google Scholar 

  44. Blaser AR, Malbrain ML, Starkopf J, et al (2012) Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM working group on abdominal problems. Intensive Care Med 38:384–394

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. Cynober.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cynober, L. Intérêts potentiels de la citrulline en réanimation. Réanimation 22, 350–357 (2013). https://doi.org/10.1007/s13546-013-0691-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13546-013-0691-x

Mots clés

Keywords

Navigation